Ljudevit Jurak Clinical Department of Pathology and Cytology, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Department of Pathology, School of Medicine, University of Zagreb, Zagreb, Croatia.
Acta Clin Croat. 2022 Oct;61(Suppl 3):9-14. doi: 10.20471/acc.2022.61.s3.1.
In prostate adenocarcinoma, both tumorous stroma and epithelium have important role in tumor progression. Transforming growth factor beta (TGF- β) is a promotor in advanced stages of prostate cancer. Matrix Metalloproteinase 2 (MMP2), the endopeptidase that degrades extracellular matrix is considered to be overexpressed in prostatic carcinoma related to its growth and aggressiveness. Therefore, the aim was to analyze the expression of proteins TGF- β and MMP2 between both epithelium and stroma of prostatic adenocarcinoma and adjacent unaffected parenchyma. The intensity of TGF- β and MMP2 expression in epithelium, tumorous stroma and adjacent unaffected parenchyma was analyzed in 62 specimens of prostatic adenocarcinoma by microarray-based immunohistochemistry. TGF- β was more expressed in tumorous than in prostate stroma (p =0.000), while no statistical significance in case of MMP2 (p = 0.097) was found. MMP2 was more expressed in tumorous than in prostate epithelium (p =0.000), while no statistical significance in case of TGF- β (p = 0.096) was observed. The study results indicate that both tumorous stroma and epithelium have a role in tumor progression and support potential role of TGF- β and MMP2 in prostatic adenocarcinoma progression.
在前列腺腺癌中,肿瘤基质和上皮均在肿瘤进展中起重要作用。转化生长因子β(TGF-β)是前列腺癌晚期的促进因子。基质金属蛋白酶 2(MMP2)是一种降解细胞外基质的内肽酶,被认为在与前列腺癌生长和侵袭性相关的肿瘤中过度表达。因此,本研究旨在分析前列腺腺癌的上皮和基质中 TGF-β和 MMP2 蛋白的表达情况,并与相邻未受影响的实质进行比较。通过基于微阵列的免疫组织化学分析了 62 例前列腺腺癌标本中 TGF-β和 MMP2 在前列腺上皮、肿瘤基质和相邻未受影响的实质中的表达强度。TGF-β在肿瘤基质中的表达高于前列腺基质(p=0.000),而 MMP2 则无统计学意义(p=0.097)。MMP2 在肿瘤上皮中的表达高于前列腺上皮(p=0.000),而 TGF-β 则无统计学意义(p=0.096)。研究结果表明,肿瘤基质和上皮均在肿瘤进展中起作用,并支持 TGF-β和 MMP2 在前列腺腺癌进展中的潜在作用。